From: Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis
Wild-type mice (n = 12) | Vps13a−/− mice (n = 12) | |
---|---|---|
Hct (%) | 45.3 ± 1.2 | 46.1 ± 0.8 |
Hb (g/dl) | 14.9 ± 0.3 | 14.2 ± 0.6 |
MCV (fl) | 52.4 ± 1.6 | 53.1 ± 1.5 |
MCH (pg) | 16.3 ± 0.8 | 15.9 ± 0.8 |
CHCM (g/dL) | 26.3 ± 0.2 | 26.2 ± 0.2 |
RDW (%) | 12.5 ± 0.4 | 12.9 ± 0.7 |
HDW (g/dL) | 2.1 ± 0.43 | 3.1 ± 0.47* |
Retics (cell/uL) | 417 ± 65 | 382 ± 84 |